Rare diseases
Investigational molecules
Locations
Back to Latvia45 clinical trials in Liepaja, Latvia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in LatviaKliniskiePetijumi.lv(opens in a new tab)LatviaLatviaLatviaLatviaLatviaLatviaLatviaLatviaLatviaLatviaLatviaLatviaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on treatments for psoriatic arthritis, ulcerative colitis, and systemic lupus erythematosus. Studies evaluate novel therapies including zasocitinib, eltrekibart, and upadacitinib for improved disease management.
Research aims to enhance treatment efficacy and patient outcomes in chronic inflammatory conditions.
Innovative studies targeting atherosclerotic cardiovascular disease and stroke prevention. Trials examine new medications like inclisiran and asundexian for managing cardiovascular risks and preventing major adverse events.
Focus on reducing cardiovascular events and improving patient outcomes in high-risk populations.
Research investigating treatments for bladder cancer and prostate cancer. Clinical trials evaluate innovative therapies including UGN-102 and novel combinations for various stages of cancer progression.
Studies aim to improve treatment options and outcomes for cancer patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
